Ascendis Pharma A (ASND) Amortizatization of Intangibles (2021 - 2025)

Ascendis Pharma A has reported Amortizatization of Intangibles for 5 years, with the latest figure at $150161.6 in Q4 2025.

• Quarterly Amortizatization of Intangibles rose 18.09% year-over-year to $150161.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $553832.8 (up 9.56% YoY) and the FY2025 annual result came in at $570381.3, up 14.3% from the prior year.
• Amortizatization of Intangibles advanced to $150161.6 in Q4 2025 per ASND's latest filing, from $143793.8 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $161391.0 in Q4 2023 and troughed at $111918.5 in Q3 2022.
• A 5-year average of $128817.0 and a median of $126729.0 in 2024 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles soared 42.51% in 2023, then dropped 21.21% in 2024.
• Over 5 years, Amortizatization of Intangibles stood at $128124.7 in 2021, then slipped by 11.61% to $113247.5 in 2022, then jumped by 42.51% to $161391.0 in 2023, then declined by 21.21% to $127162.9 in 2024, then increased by 18.09% to $150161.6 in 2025.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $150161.6, $143793.8, and $134703.2 for Q4 2025, Q3 2025, and Q2 2025 respectively.